Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors

NCT03095248 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Results review of patient data

Conditions

Neurofibromatosis 2
Vestibular Schwannoma
Meningioma
Ependymoma
Glioma

Interventions

DRUG: Selumetinib

Sponsor

Children's Hospital Medical Center, Cincinnati

Collaborators

[object Object]